Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Huddart

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Trials|March 17, 2011
Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)Sangeetha Paramasivan, Robert Huddart, Emma Hall, et al.
Neoplasia (New York, N.Y.)|December 16, 2005
Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumorsAlan McIntyre, Brenda Summersgill, Hayley E Spendlove, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
A randomised trial of accelerated radiotherapy for localised invasive bladder cancerAlan Horwich, David Dearnaley, Robert Huddart, et al.
BJU International|April 21, 2005
Early outcomes of active surveillance for localized prostate cancerClaire Hardie, Chris Parker, Andrew Norman, et al.
European Urology Open Science|November 1, 2021
Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data SetAdam Kieran Pearce, David Manson-Bahr, Alison Reid, et al.
BJU International|September 14, 2007
Prostate-specific antigen velocity in untreated, localized prostate cancerRamachandran Venkitaraman, Andrew Norman, Ruth Woode-Amissah, et al.
European Urology Focus|August 2, 2024
Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell TumourChristoph Oing, Pasquale Rescigno, Pia Paffenholz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivationChris Parker, Padraig Warde, Andy Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Prospective study of factors predicting adherence to medical advice in men with testicular cancerClare Moynihan, Andy R Norman, Yolanda Barbachano, et al.
Psycho-Oncology|December 19, 2003
Prostate cancer patients' support and psychological care needs: Survey from a non-surgical oncology clinicKathleen Lintz, Clare Moynihan, Suzanne Steginga, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Trials|March 17, 2011
Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)Sangeetha Paramasivan, Robert Huddart, Emma Hall, et al.
Neoplasia (New York, N.Y.)|December 16, 2005
Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumorsAlan McIntyre, Brenda Summersgill, Hayley E Spendlove, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 10, 2005
A randomised trial of accelerated radiotherapy for localised invasive bladder cancerAlan Horwich, David Dearnaley, Robert Huddart, et al.
BJU International|April 21, 2005
Early outcomes of active surveillance for localized prostate cancerClaire Hardie, Chris Parker, Andrew Norman, et al.
European Urology Open Science|November 1, 2021
Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data SetAdam Kieran Pearce, David Manson-Bahr, Alison Reid, et al.
BJU International|September 14, 2007
Prostate-specific antigen velocity in untreated, localized prostate cancerRamachandran Venkitaraman, Andrew Norman, Ruth Woode-Amissah, et al.
European Urology Focus|August 2, 2024
Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell TumourChristoph Oing, Pasquale Rescigno, Pia Paffenholz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivationChris Parker, Padraig Warde, Andy Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Prospective study of factors predicting adherence to medical advice in men with testicular cancerClare Moynihan, Andy R Norman, Yolanda Barbachano, et al.
Psycho-Oncology|December 19, 2003
Prostate cancer patients' support and psychological care needs: Survey from a non-surgical oncology clinicKathleen Lintz, Clare Moynihan, Suzanne Steginga, et al.
Pageof 12